. 2019 Jul 23;24:432–438. doi: 10.12659/AOT.916012

Table 5.

Mean serum creatinine and frequency of normal/high values on last follow-up.

	Cohort
	GI (Up to 45)	GII (45–60)	GIII (>60)	Significance
No of cases	55	32	14	One-way Anova	Turky HSD
Mean SC μmol/L	84.3±21.3	96.1±28.4	93.3±30.8	P=0.09	GI vs. GII	P=0.09
					GI vs. GIII	P=0.43
					GII vs. GIII	P=0.93
SC within normal range (115 μmol/L or less)	50 (91%)	26 (81%)	11 (79%)	GI vs. GII		0.19
SC above normal range (>115 μmol/L)	5 (9%)	6 (19%)	3 (21%)	GI vs. GIII		0.19
SC above normal range (>115 μmol/L)	5 (9%)	6 (19%)	3 (21%)	GI vs. rest		0.15
	IGF vs. graft dysfunction (DGF or SGF)
	IGF		DGF	Significance		Risk estimates
Total No of cases	95		6
Mean SC μmol/L	87.8±23.7 95% CI		112.8±41.7	P=0.02		95% CI −45.8 – −4.2
SC within normal range (115 μmol/L or less)	83 (87%)		4 (67%)	P=.19		Odd ratio 3.5: 95% CI −0.6–20.96
SC above normal range (>115 μmol/L)	12 (13%)		2 (33%)	P=.19		Odd ratio 3.5: 95% CI −0.6–20.96